Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 22 | 2024 | 891 | 8.350 |
Why?
|
| Metformin | 4 | 2021 | 395 | 1.800 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 1052 | 1.350 |
Why?
|
| Obesity | 6 | 2022 | 2940 | 1.270 |
Why?
|
| Particulate Matter | 3 | 2024 | 84 | 1.180 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 108 | 1.170 |
Why?
|
| Air Filters | 2 | 2024 | 2 | 1.130 |
Why?
|
| Environmental Exposure | 3 | 2022 | 283 | 1.110 |
Why?
|
| Glucose | 2 | 2023 | 1249 | 1.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 1445 | 1.070 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 156 | 1.040 |
Why?
|
| Wildfires | 1 | 2024 | 1 | 0.940 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2024 | 567 | 0.870 |
Why?
|
| Triglycerides | 2 | 2023 | 618 | 0.800 |
Why?
|
| Schools | 2 | 2022 | 236 | 0.780 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 30 | 0.750 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 1077 | 0.710 |
Why?
|
| Urban Population | 2 | 2019 | 281 | 0.700 |
Why?
|
| Air Pollution, Indoor | 4 | 2021 | 40 | 0.700 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 623 | 0.690 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 320 | 0.680 |
Why?
|
| Family Characteristics | 1 | 2019 | 95 | 0.630 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 863 | 0.600 |
Why?
|
| Smokers | 1 | 2019 | 148 | 0.600 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 374 | 0.580 |
Why?
|
| Insulin Resistance | 1 | 2021 | 748 | 0.500 |
Why?
|
| Air Pollutants | 3 | 2022 | 135 | 0.490 |
Why?
|
| Smoking | 2 | 2020 | 2427 | 0.450 |
Why?
|
| Primary Health Care | 1 | 2019 | 842 | 0.410 |
Why?
|
| Humans | 37 | 2024 | 271062 | 0.380 |
Why?
|
| Air Pollution | 2 | 2022 | 82 | 0.370 |
Why?
|
| Spirometry | 2 | 2022 | 147 | 0.360 |
Why?
|
| Respiratory Sounds | 2 | 2022 | 93 | 0.360 |
Why?
|
| United States | 8 | 2022 | 16011 | 0.340 |
Why?
|
| Respiratory Function Tests | 2 | 2021 | 354 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2293 | 0.320 |
Why?
|
| Cohort Studies | 6 | 2023 | 9438 | 0.320 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 316 | 0.310 |
Why?
|
| Oximetry | 3 | 2023 | 188 | 0.290 |
Why?
|
| Pediatric Obesity | 2 | 2023 | 378 | 0.290 |
Why?
|
| Hospitalization | 3 | 2021 | 2198 | 0.280 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5908 | 0.270 |
Why?
|
| Blood Glucose | 2 | 2021 | 1288 | 0.260 |
Why?
|
| Adult | 9 | 2024 | 81619 | 0.240 |
Why?
|
| Risk Factors | 4 | 2023 | 17829 | 0.240 |
Why?
|
| Retrospective Studies | 8 | 2023 | 39721 | 0.230 |
Why?
|
| Smoke | 1 | 2024 | 61 | 0.230 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 299 | 0.220 |
Why?
|
| Female | 16 | 2024 | 148623 | 0.220 |
Why?
|
| Male | 13 | 2024 | 128516 | 0.220 |
Why?
|
| Emphysema | 1 | 2024 | 88 | 0.210 |
Why?
|
| Lymphadenopathy | 1 | 2024 | 94 | 0.210 |
Why?
|
| Comorbidity | 2 | 2021 | 2434 | 0.210 |
Why?
|
| Achievement | 1 | 2022 | 40 | 0.210 |
Why?
|
| Baltimore | 2 | 2019 | 23 | 0.210 |
Why?
|
| Neck Pain | 1 | 2022 | 41 | 0.210 |
Why?
|
| Child | 9 | 2023 | 30373 | 0.210 |
Why?
|
| Biomarkers | 3 | 2023 | 5107 | 0.200 |
Why?
|
| Blast Injuries | 1 | 2022 | 61 | 0.200 |
Why?
|
| Sarcoidosis | 1 | 2022 | 114 | 0.200 |
Why?
|
| Oxygen | 2 | 2023 | 800 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 51 | 0.190 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2021 | 25 | 0.190 |
Why?
|
| Information Systems | 1 | 2021 | 68 | 0.180 |
Why?
|
| Veterans | 2 | 2022 | 1773 | 0.180 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 153 | 0.180 |
Why?
|
| Positive-Pressure Respiration, Intrinsic | 1 | 2020 | 3 | 0.180 |
Why?
|
| Students | 1 | 2022 | 330 | 0.170 |
Why?
|
| Disease Progression | 3 | 2021 | 6898 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 966 | 0.170 |
Why?
|
| Dyspnea | 2 | 2022 | 420 | 0.170 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2019 | 20 | 0.170 |
Why?
|
| Acute Disease | 1 | 2024 | 2511 | 0.170 |
Why?
|
| Middle Aged | 8 | 2024 | 90103 | 0.160 |
Why?
|
| Symptom Assessment | 1 | 2021 | 274 | 0.160 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 248 | 0.160 |
Why?
|
| Overweight | 2 | 2023 | 486 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 83 | 0.160 |
Why?
|
| Cough | 1 | 2018 | 126 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2024 | 33851 | 0.150 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 583 | 0.140 |
Why?
|
| Propensity Score | 1 | 2019 | 775 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2020 | 742 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 665 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 4507 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2019 | 16930 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2019 | 939 | 0.110 |
Why?
|
| Lung | 2 | 2022 | 3271 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2021 | 969 | 0.110 |
Why?
|
| Inflammation | 1 | 2022 | 2525 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2019 | 2286 | 0.100 |
Why?
|
| Aged | 5 | 2021 | 73250 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1230 | 0.100 |
Why?
|
| Tidal Volume | 2 | 2022 | 58 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 5087 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 2237 | 0.090 |
Why?
|
| Quality of Life | 1 | 2024 | 4740 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 15249 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6187 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4389 | 0.080 |
Why?
|
| Adolescent | 2 | 2019 | 32554 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 30966 | 0.070 |
Why?
|
| Snoring | 1 | 2023 | 12 | 0.060 |
Why?
|
| Afghanistan | 1 | 2022 | 11 | 0.050 |
Why?
|
| Iraq | 1 | 2022 | 11 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 104 | 0.050 |
Why?
|
| Peru | 1 | 2020 | 60 | 0.050 |
Why?
|
| Prognosis | 1 | 2018 | 22464 | 0.050 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 99 | 0.040 |
Why?
|
| Young Adult | 1 | 2019 | 22063 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 321 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 337 | 0.040 |
Why?
|
| Hypoxia | 1 | 2022 | 468 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 1173 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 476 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 1437 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2022 | 13375 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 454 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1313 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1597 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 5165 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 7224 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 36039 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 62826 | 0.010 |
Why?
|